Tower Research Capital (TRC)’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-7,135
| Closed | -$2.84K | – | 6414 |
|
|
2023
Q3 | $2.84K | Sell |
7,135
-15
| -0.2% | -$7 | ﹤0.01% | 5095 |
|
|
2023
Q2 | $4.93K | Buy |
7,150
+6,664
| +1,371% | +$42.9K | ﹤0.01% | 4885 |
|
|
2023
Q1 | $4K | Sell |
486
-5,386
| -92% | -$18.8K | ﹤0.01% | 5159 |
|
|
2022
Q4 | $5K | Sell |
5,872
-1,689
| -22% | -$1.73K | ﹤0.01% | 4961 |
|
|
2022
Q3 | $8K | Sell |
7,561
-3,064
| -29% | -$4.01K | ﹤0.01% | 4854 |
|
|
2022
Q2 | $13K | Buy |
10,625
+9,049
| +574% | +$12.1K | ﹤0.01% | 4263 |
|
|
2022
Q1 | $4K | Buy |
1,576
+878
| +126% | +$2.09K | ﹤0.01% | 5335 |
|
|
2021
Q4 | $2K | Buy |
+698
| New | +$2.32K | ﹤0.01% | 5765 |
|
|
2021
Q2 | – | Sell |
-2,131
| Closed | -$11K | – | 6338 |
|
|
2021
Q1 | $11K | Buy |
2,131
+689
| +48% | +$4.8K | ﹤0.01% | 4353 |
|
|
2020
Q4 | $10K | Sell |
1,442
-2,110
| -59% | -$17.3K | ﹤0.01% | 4360 |
|
|
2020
Q3 | $36K | Buy |
3,552
+3,381
| +1,977% | +$39.8K | ﹤0.01% | 3671 |
|
|
2020
Q2 | $2K | Buy |
+171
| New | +$2.39K | ﹤0.01% | 4574 |
|
|
2017
Q4 | – | Sell |
-7
| Closed | – | – | 4301 |
|
|
2017
Q3 | $0 | Buy |
+7
| New | +$130 | ﹤0.01% | 4325 |
|
|
2016
Q4 | – | Sell |
-47
| Closed | -$1K | – | 4701 |
|
|
2016
Q3 | $1K | Sell |
47
-2
| -4% | -$48 | ﹤0.01% | 3444 |
|
|
2016
Q2 | $1K | Hold |
49
| – | – | ﹤0.01% | 4282 |
|
|
2016
Q1 | $2K | Buy |
+49
| New | +$1.82K | ﹤0.01% | 3517 |
|
|
2015
Q4 | – | Sell |
-13
| Closed | -$1K | – | 5350 |
|
|
2015
Q3 | $1K | Sell |
13
-10
| -43% | -$770 | ﹤0.01% | 3756 |
|
|
2015
Q2 | $3K | Buy |
23
+1
| +5% | +$136 | ﹤0.01% | 3616 |
|
|
2015
Q1 | $3K | Buy |
+22
| New | +$3.42K | ﹤0.01% | 3641 |
|
Other funds holding BLPH
Tower Research Capital (TRC)'s BLPH Position: Q4 2023 in Review
Tower Research Capital (TRC) sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q4 2023, closing a stake of 7,135 shares — an estimated $2.84K sold.
Tower Research Capital (TRC) first reported a position in BLPH in Q1 2015 and held it in 19 quarters. The position peaked at $36K in Q3 2020. 2 funds tracked by Wall St. Rank hold BLPH as of Q4 2023.
- Tower Research Capital (TRC) reported no remaining Bellerophon Therapeutics, Inc. position as of Q4 2023 after selling out during the quarter.
- Tower Research Capital (TRC) sold 7,135 Bellerophon Therapeutics, Inc. shares in Q4 2023, an estimated $2.84K.
- Tower Research Capital (TRC) first reported a position in Bellerophon Therapeutics, Inc. in Q1 2015 and held it in 19 quarters.
- Tower Research Capital (TRC)'s Bellerophon Therapeutics, Inc. position peaked at $36K in Q3 2020.
- 2 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q4 2023.
Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.